September 30,
2021

December 31,
2020

Accrued clinical operations and trials costs

$

8,431,267

$

14,132,842

Accrued product development costs

240,648

2,189,047

Accrued compensation

3,337,362

4,222,594

Accrued other

1,358,856

1,460,949

Total

$

13,368,133

$

22,005,432